{"transactions":[{"id":722772,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-01T00:38:34.000Z","date":"2026-06-30","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":35.45,"value":7090000.0,"ownership":{"direct":true},"balance_after":1748403,"source":{"system":"sec-edgar","filing":"0001193125-26-291172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526291172/ownership.xml","form_type":"4"}},{"id":722771,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-01T00:38:34.000Z","date":"2026-06-30","kind":"sale","planned":false,"acquired":false,"shares":12380,"price":35.28,"value":436766.4,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":13689166,"source":{"system":"sec-edgar","filing":"0001193125-26-291172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526291172/ownership.xml","form_type":"4"}},{"id":722770,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-01T00:38:34.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":false,"shares":600000,"price":34.59,"value":20754000.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":13701546,"source":{"system":"sec-edgar","filing":"0001193125-26-291172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526291172/ownership.xml","form_type":"4"}},{"id":722769,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-01T00:38:34.000Z","date":"2026-06-29","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":34.44,"value":6888000.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":14301546,"source":{"system":"sec-edgar","filing":"0001193125-26-291172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526291172/ownership.xml","form_type":"4"}},{"id":722768,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-01T00:38:34.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":325000,"price":34.07,"value":11072750.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":14501546,"source":{"system":"sec-edgar","filing":"0001193125-26-291172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526291172/ownership.xml","form_type":"4"}},{"id":722767,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-07-01T00:38:34.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":300783,"price":33.92,"value":10202559.36,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":14826546,"source":{"system":"sec-edgar","filing":"0001193125-26-291172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526291172/ownership.xml","form_type":"4"}},{"id":905156,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-14T02:02:15.000Z","date":"2026-02-13","kind":"sale","planned":false,"acquired":false,"shares":225000,"price":26.5,"value":5962500.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":15127329,"source":{"system":"sec-edgar","filing":"0001193125-26-052130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526052130/ownership.xml","form_type":"4"}},{"id":905155,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-14T02:02:15.000Z","date":"2026-02-13","kind":"sale","planned":false,"acquired":false,"shares":150784,"price":26.49,"value":3994268.16,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":15352329,"source":{"system":"sec-edgar","filing":"0001193125-26-052130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526052130/ownership.xml","form_type":"4"}},{"id":905154,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-14T02:02:15.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":275000,"price":26.76,"value":7359000.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":15503113,"source":{"system":"sec-edgar","filing":"0001193125-26-052130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526052130/ownership.xml","form_type":"4"}},{"id":905153,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-14T02:02:15.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":26.72,"value":4008000.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":15778113,"source":{"system":"sec-edgar","filing":"0001193125-26-052130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526052130/ownership.xml","form_type":"4"}},{"id":905152,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-02-14T02:02:15.000Z","date":"2026-02-11","kind":"sale","planned":false,"acquired":false,"shares":425000,"price":26.67,"value":11334750.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":15928113,"source":{"system":"sec-edgar","filing":"0001193125-26-052130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312526052130/ownership.xml","form_type":"4"}},{"id":963129,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-12-19T00:52:36.000Z","date":"2025-12-17","kind":"sale","planned":false,"acquired":false,"shares":189538,"price":23.17,"value":4391595.46,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":16353113,"source":{"system":"sec-edgar","filing":"0001193125-25-325355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525325355/ownership.xml","form_type":"4"}},{"id":963128,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-12-19T00:52:36.000Z","date":"2025-12-17","kind":"sale","planned":false,"acquired":false,"shares":155076,"price":23.02,"value":3569849.52,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":16542651,"source":{"system":"sec-edgar","filing":"0001193125-25-325355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525325355/ownership.xml","form_type":"4"}},{"id":963127,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-12-19T00:52:36.000Z","date":"2025-12-17","kind":"sale","planned":false,"acquired":false,"shares":432718,"price":23.05,"value":9974149.9,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":16697727,"source":{"system":"sec-edgar","filing":"0001193125-25-325355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525325355/ownership.xml","form_type":"4"}},{"id":963126,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-12-19T00:52:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":642282,"price":23.08,"value":14823868.56,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":17130445,"source":{"system":"sec-edgar","filing":"0001193125-25-325355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525325355/ownership.xml","form_type":"4"}},{"id":963125,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-12-19T00:52:36.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":275000,"price":22.93,"value":6305750.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":17772727,"source":{"system":"sec-edgar","filing":"0001193125-25-325355","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525325355/ownership.xml","form_type":"4"}},{"id":991299,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-22T01:24:55.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":175000,"price":20.24,"value":3542000.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":18047727,"source":{"system":"sec-edgar","filing":"0001193125-25-291734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525291734/ownership.xml","form_type":"4"}},{"id":991298,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-22T01:24:55.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":125000,"price":20.16,"value":2520000.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":18222727,"source":{"system":"sec-edgar","filing":"0001193125-25-291734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525291734/ownership.xml","form_type":"4"}},{"id":991297,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-22T01:24:55.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":20.2,"value":3030000.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":18347727,"source":{"system":"sec-edgar","filing":"0001193125-25-291734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525291734/ownership.xml","form_type":"4"}},{"id":991296,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-22T01:24:55.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":850000,"price":20.25,"value":17212500.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. (\"QVT FIC\") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":18497727,"source":{"system":"sec-edgar","filing":"0001193125-25-291734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000119312525291734/ownership.xml","form_type":"4"}},{"id":1041535,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-13T01:00:28.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":33726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."}],"balance_after":33726,"derivative":{"exercise_price":13.77,"expiration_date":"2035-09-09","underlying":"Common Shares","underlying_shares":33726},"source":{"system":"sec-edgar","filing":"0001140361-25-034934","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125034934/form4.xml","form_type":"4"}},{"id":1041534,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-09-13T01:00:28.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":14524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date."}],"balance_after":1948403,"source":{"system":"sec-edgar","filing":"0001140361-25-034934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125034934/form4.xml","form_type":"4"}},{"id":1100179,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-27T21:00:10.000Z","date":"2025-06-25","kind":"other","planned":false,"acquired":false,"shares":1170646,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT P&E Roiv Hldgs Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd., a related fund, contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":1592480,"source":{"system":"sec-edgar","filing":"0000950170-25-090994","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017025090994/ownership.xml","form_type":"4"}},{"id":1100178,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-27T21:00:10.000Z","date":"2025-06-25","kind":"other","planned":false,"acquired":false,"shares":6837266,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT Roiv Hldgs Onshore Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd., a related fund, contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-090994","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017025090994/ownership.xml","form_type":"4"}},{"id":1100177,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-27T21:00:10.000Z","date":"2025-06-25","kind":"other","planned":false,"acquired":false,"shares":3176245,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd., a related fund, contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":19347727,"source":{"system":"sec-edgar","filing":"0000950170-25-090994","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017025090994/ownership.xml","form_type":"4"}},{"id":1100176,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-27T21:00:10.000Z","date":"2025-06-25","kind":"other","planned":false,"acquired":false,"shares":6205368,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT Deferred Compensation Holdings Ltd"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 25, 2025, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration. One of the investors in QVT Roiv Hldgs Offshore Ltd., a related fund, contributed its pro rata portion distribution to QVT FIC in order to facilitate the winding down of QVT Roiv Hldgs Offshore Ltd. QVT FIC has no pecuniary interest in such shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":8441428,"source":{"system":"sec-edgar","filing":"0000950170-25-090994","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017025090994/ownership.xml","form_type":"4"}},{"id":1398973,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-09-27T00:35:40.000Z","date":"2024-09-25","kind":"sale","planned":false,"acquired":false,"shares":134948,"price":11.7653,"value":1587703.7044,"ownership":{"direct":true},"balance_after":1277178,"source":{"system":"sec-edgar","filing":"0000950170-24-109733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017024109733/ownership.xml","form_type":"4"}},{"id":1398972,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-09-27T00:35:40.000Z","date":"2024-09-24","kind":"sale","planned":false,"acquired":false,"shares":368052,"price":11.625,"value":4278604.5,"ownership":{"direct":true},"balance_after":1412126,"source":{"system":"sec-edgar","filing":"0000950170-24-109733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017024109733/ownership.xml","form_type":"4"}},{"id":1408591,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-13T01:00:22.000Z","date":"2024-09-10","kind":"grant","planned":false,"acquired":true,"shares":27894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."}],"balance_after":27894,"derivative":{"exercise_price":12.19,"expiration_date":"2034-09-09","underlying":"Common Shares","underlying_shares":27894},"source":{"system":"sec-edgar","filing":"0001140361-24-040988","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124040988/form4.xml","form_type":"4"}},{"id":1408590,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-09-13T01:00:22.000Z","date":"2024-09-10","kind":"grant","planned":false,"acquired":true,"shares":16406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date."}],"balance_after":1780178,"source":{"system":"sec-edgar","filing":"0001140361-24-040988","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036124040988/form4.xml","form_type":"4"}},{"id":1431246,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-16T20:07:41.000Z","date":"2024-08-14","kind":"exercise","planned":false,"acquired":false,"shares":54915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This is a director stock option grant that is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.56,"expiration_date":"2024-11-13","underlying":"Common Shares","underlying_shares":54915},"source":{"system":"sec-edgar","filing":"0001447028-24-000078","document":"wk-form4_1723838854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000078/wk-form4_1723838854.xml","form_type":"4"}},{"id":1431245,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-08-16T20:07:41.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":8846,"price":3.6895,"value":32637.317,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold."}],"balance_after":46069,"source":{"system":"sec-edgar","filing":"0001447028-24-000078","document":"wk-form4_1723838854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000078/wk-form4_1723838854.xml","form_type":"4"}},{"id":1431244,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-08-16T20:07:41.000Z","date":"2024-08-14","kind":"exercise","planned":false,"acquired":true,"shares":54915,"price":0.56,"value":30752.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold."}],"balance_after":54915,"source":{"system":"sec-edgar","filing":"0001447028-24-000078","document":"wk-form4_1723838854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000078/wk-form4_1723838854.xml","form_type":"4"}},{"id":1501883,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T20:16:11.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":67000,"derivative":{"exercise_price":3.28,"exercise_date":"2024-05-23","expiration_date":"2034-05-23","underlying":"Common Shares","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001447028-24-000057","document":"wk-form4_1716581747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702824000057/wk-form4_1716581747.xml","form_type":"4"}},{"id":1589105,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-07T23:35:39.000Z","date":"2024-03-07","kind":"other","planned":false,"acquired":false,"shares":2260661,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT P&E Roiv Hldgs Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":2763126,"source":{"system":"sec-edgar","filing":"0000950170-24-028216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017024028216/ownership.xml","form_type":"4"}},{"id":1589104,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-07T23:35:39.000Z","date":"2024-03-07","kind":"other","planned":false,"acquired":false,"shares":5594064,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT Roiv Hldgs Onshore Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":6837266,"source":{"system":"sec-edgar","filing":"0000950170-24-028216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017024028216/ownership.xml","form_type":"4"}},{"id":1589103,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-07T23:35:39.000Z","date":"2024-03-07","kind":"other","planned":false,"acquired":false,"shares":11325233,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":23105358,"source":{"system":"sec-edgar","filing":"0000950170-24-028216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017024028216/ownership.xml","form_type":"4"}},{"id":1589102,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-07T23:35:39.000Z","date":"2024-03-07","kind":"other","planned":false,"acquired":false,"shares":11077765,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by QVT Deferred Compensation Holdings Ltd"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. (together, \"QVT Roiv\"), QVT P&E Roiv Hldgs Ltd. (\"QVT P&E\"), QVT Deferred Compensation Holdings Ltd (\"QVT DCH\") and QVT Financial Investment Cayman Ltd. (\"QVT FIC\") made an in-kind distribution on a pro rata basis, for no consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT FIC (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":14646796,"source":{"system":"sec-edgar","filing":"0000950170-24-028216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017024028216/ownership.xml","form_type":"4"}},{"id":1770420,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-10-03T01:05:20.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":446394,"price":11.55,"value":5155850.7,"ownership":{"direct":false,"nature":"Held by QVT P&E Roiv Hldgs Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":5023787,"source":{"system":"sec-edgar","filing":"0000950170-23-051250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017023051250/ownership.xml","form_type":"4"}},{"id":1770419,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-10-03T01:05:20.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":1104599,"price":11.55,"value":12758118.45,"ownership":{"direct":false,"nature":"Held by QVT Roiv Hldgs Onshore Ltd"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":12431330,"source":{"system":"sec-edgar","filing":"0000950170-23-051250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017023051250/ownership.xml","form_type":"4"}},{"id":1770418,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-10-03T01:05:20.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":3059368,"price":11.55,"value":35335700.4,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":34430591,"source":{"system":"sec-edgar","filing":"0000950170-23-051250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017023051250/ownership.xml","form_type":"4"}},{"id":1770417,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-10-03T01:05:20.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":2285783,"price":11.55,"value":26400793.65,"ownership":{"direct":false,"nature":"Held by QVT Deferred Compensation Holdings Ltd"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":25724561,"source":{"system":"sec-edgar","filing":"0000950170-23-051250","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000095017023051250/ownership.xml","form_type":"4"}},{"id":1781028,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T01:30:57.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":true,"shares":26595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date."}],"balance_after":26595,"derivative":{"exercise_price":11.22,"expiration_date":"2033-09-11","underlying":"Common Shares","underlying_shares":26595},"source":{"system":"sec-edgar","filing":"0001140361-23-044041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044041/form4.xml","form_type":"4"}},{"id":1781027,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-09-15T01:30:57.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":true,"shares":17825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100%  on September 12, 2024, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100%  on September 12, 2024, subject generally to the reporting person's continuous service through such date."}],"balance_after":69967,"source":{"system":"sec-edgar","filing":"0001140361-23-044041","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123044041/form4.xml","form_type":"4"}},{"id":1876388,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-26T20:18:08.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":55000,"derivative":{"exercise_price":2.56,"exercise_date":"2023-05-24","expiration_date":"2033-05-24","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001447028-23-000044","document":"wk-form4_1685132251.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702823000044/wk-form4_1685132251.xml","form_type":"4"}},{"id":2117922,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-15T02:43:08.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":146079,"price":4.75,"value":693875.25,"ownership":{"direct":false,"nature":"Held by QVT P&E Roiv Hldgs Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":5470181,"source":{"system":"sec-edgar","filing":"0000899243-22-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000089924322035815/doc4.xml","form_type":"4"}},{"id":2117921,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-15T02:43:08.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":2311643,"price":4.75,"value":10980304.25,"ownership":{"direct":false,"nature":"Held by QVT Deferred Compensation Holdings Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":28010344,"source":{"system":"sec-edgar","filing":"0000899243-22-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000089924322035815/doc4.xml","form_type":"4"}},{"id":2117920,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-15T02:43:08.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":372427,"price":4.75,"value":1769028.25,"ownership":{"direct":false,"nature":"Held by QVT Roiv Hldgs Onshore Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":13535929,"source":{"system":"sec-edgar","filing":"0000899243-22-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000089924322035815/doc4.xml","form_type":"4"}},{"id":2117919,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-15T02:43:08.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":1092355,"price":4.75,"value":5188686.25,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":37489959,"source":{"system":"sec-edgar","filing":"0000899243-22-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000089924322035815/doc4.xml","form_type":"4"}},{"id":2117918,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-15T02:43:08.000Z","date":"2022-11-09","kind":"other","acquired":false,"shares":1196200,"ownership":{"direct":false,"nature":"Held by QVT Financial Investment Cayman Ltd."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were distributed in-kind to certain shareholders of QVT Financial Investment Cayman Ltd. who subsequently gifted the shares to charitable foundations, each of which is subject to a lock-up."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the \"QVT Entities\") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose."}],"balance_after":38582314,"source":{"system":"sec-edgar","filing":"0000899243-22-035815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000089924322035815/doc4.xml","form_type":"4"}},{"id":2155695,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-20T01:53:52.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":71850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 15, 2023, subject generally to the reporting person's continuous service through such date."}],"balance_after":71850,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-14","underlying":"Common Shares","underlying_shares":71850},"source":{"system":"sec-edgar","filing":"0001140361-22-033880","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036122033880/form4.xml","form_type":"4"}},{"id":2155694,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true}}],"security":"Common Shares","published_at":"2022-09-20T01:53:52.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":52142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100%  on September 15, 2023, subject generally to the reporting person's continuous service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects an annual award of restricted stock units with respect to Common Shares (\"RSUs\") granted pursuant to the Company's2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy.  The award of RSUs is scheduled to vest 100%  on September 15, 2023, subject generally to the reporting person's continuous service through such date."}],"balance_after":52142,"source":{"system":"sec-edgar","filing":"0001140361-22-033880","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635088/000114036122033880/form4.xml","form_type":"4"}},{"id":2255138,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-26T20:10:59.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable as of the date of the grant."}],"balance_after":41000,"derivative":{"exercise_price":2.25,"exercise_date":"2022-05-25","expiration_date":"2032-05-25","underlying":"Common Shares","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001447028-22-000033","document":"wf-form4_165359582944568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702822000033/wf-form4_165359582944568.xml","form_type":"4"}},{"id":2679209,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-06-07T20:24:43.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on June 3, 2021, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested and exercisable as of the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":2.95,"exercise_date":"2021-06-03","expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-21-000041","document":"wf-form4_162309747011064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702821000041/wf-form4_162309747011064.xml","form_type":"4"}},{"id":3128970,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-01T20:57:22.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 28, 2020, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are fully vested and exercisable as of the date of the grant."}],"balance_after":22000,"derivative":{"exercise_price":2.16,"exercise_date":"2020-05-28","expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-20-000064","document":"wf-form4_159104502505994.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702820000064/wf-form4_159104502505994.xml","form_type":"4"}},{"id":3433123,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-08-20T20:16:19.000Z","date":"2019-08-17","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on August 16, 2019, the trading day immediately preceding the date of the grant."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Dr. Manchester is the Head of Life Sciences and a Portfolio Manager at QVT Financial LP and serves as a director on behalf of QVT Financial LP and its affiliates. Dr. Manchester holds these stock options for the benefit of certain funds managed by QVT Financial LP."}],"balance_after":22000,"derivative":{"exercise_price":1.5,"exercise_date":"2019-08-17","expiration_date":"2029-08-17","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001447028-19-000052","document":"wf-form4_156633216383352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702819000052/wf-form4_156633216383352.xml","form_type":"4"}},{"id":3884991,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-06-22T21:01:19.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option fully vested on June 19, 2018."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Dr. Manchester is the Head of Life Sciences and a Portfolio Manager at QVT Financial LP and serves as a director on behalf of QVT Financial LP and its affiliates. Dr. Manchester holds these stock options for the benefit of certain funds managed by QVT Financial LP."}],"balance_after":22000,"derivative":{"exercise_price":6.75,"exercise_date":"2018-06-19","expiration_date":"2028-06-19","underlying":"Common Shares","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001140361-18-029621","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000114036118029621/doc1.xml","form_type":"4"}},{"id":4273474,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":34463,"kind":"person","name":"MANCHESTER KEITH S","position":1,"cik":"0001244828","reported_name":"MANCHESTER KEITH S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T20:33:35.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option fully vested on June 21, 2017."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Dr. Manchester is the Head of Life Sciences and a Portfolio Manager at QVT Financial LP and serves as a director on behalf of QVT Financial LP and its affiliates. Dr. Manchester holds these stock options for the benefit of certain funds managed by QVT Financial LP."}],"balance_after":22000,"derivative":{"exercise_price":3.55,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-17-041664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000120919117041664/doc4.xml","form_type":"4"}}]}